Retrospective study to assess the efficacy and safety of checkpoint inhibitors in advanced urothelial carcinoma in real-world setting.

被引:0
|
作者
Sevillano Fernandez, Elena
Puente, Javier
Vidal, Natalia
Pinto, Alvaro
Garcia Sanchez, Lourdes
Fiorini, Aldo
Chara Velarde, Luis Enrique
Nalda Ariza, Irene
Cassinello, Javier
Rodriguez, Angel
Galvan Ruiz, Saray
Francisco Rodriguez-Moreno, Juan
Barquin, Arantzazu
Ruiz, Sergio
Navarro, Paloma
Yague, Monica
Grande, Enrique
Garcia-Donas, Jesus
机构
[1] HM Hosp, Madrid, Spain
[2] Hosp Univ Clin San Carlos, Madrid, Spain
[3] Hosp Clin San Carlos, Madrid, Spain
[4] La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain
[5] Hosp Gen Segovia, Segovia, Spain
[6] Hosp Univ Guadalajara, Guadalajara, Spain
[7] Hosp Leon, Leon, Spain
[8] Hosp Univ Gran Canaria Doctor Negrin, Med Oncol Unit, Las Palmas Gran Canaria, Spain
[9] HM Hosp Ctr Integral Oncol Clara Campal, Madrid, Spain
[10] Lab Translat Oncol CIOCC, Madrid, Spain
[11] MD Anderson Canc Ctr, Madrid, Spain
[12] Fdn Hosp Madrid, Madrid, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17043
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis
    Cheon, Jaekyung
    Chon, Hong Jae
    Bang, Yeonghak
    Park, Neung Hwa
    Shin, Jung Woo
    Kim, Kang Mo
    Lee, Han Chu
    Lee, Jooho
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    LIVER CANCER, 2020, 9 (05) : 613 - 624
  • [42] Real-world efficacy and safety of lenvatinib in Korean patients with advanced hepatocellular carcinoma: A multicenter retrospective analysis
    Cheon, J.
    Yoo, C.
    Bang, Y.
    Chon, H.
    Ryoo, B-Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1308 - S1308
  • [43] Efficacy and safety of immune checkpoint inhibitors in heavily pretreated patients with microsatellite stable metastatic colorectal cancer: a real-world retrospective study
    Zhao, Wensi
    Chen, Yongshun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (11): : 5378 - 5388
  • [44] Real-World Efficacy and Safety of Off-Label Use of Immune Checkpoint Inhibitors (ICI) in Cancer: A Retrospective Cohort Study in Qatar
    Abaza, S.
    Nasser, S.
    Abuyounis, M.
    Nounou, A.
    Rasul, K.
    Hamad, A.
    Elazzazy, S.
    DRUG SAFETY, 2022, 45 (10) : 1300 - 1301
  • [45] Efficacy and safety of immune checkpoint inhibitor rechallenge in advanced lung cancer: A multicenter, real-world study
    Jin, Z.
    ANNALS OF ONCOLOGY, 2024, 35 : S851 - S852
  • [46] Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world
    Hao, Wen
    Liu, Wenjing
    Chang, Ruimin
    Yang, Mi
    Xin, Kai
    Liu, Jingxin
    Wang, Yibing
    Ren, Meijin
    Xie, Jiaqi
    Yang, Yang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (04)
  • [47] Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: Real-world evidence
    Hein, Erica C. Koch
    Vilbert, Maysa
    Hirsch, Ian
    Ribeiro, Mauricio Fernando
    Mantle, Luke
    Fournier, Cynthia
    Butler, Marcus O.
    Spreafico, Anna
    Saibil, Samuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] The safety and efficacy of cadonilimab in the treatment of advanced and metastatic cervical cancer: A retrospective, real-world study
    Fan, Shi
    Wang, Tao
    Zhang, Qiying
    Wang, Juan
    Su, Jin
    Zhang, Jing
    Wang, Fei
    Liu, Zi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Efficacy and Adverse Events of PD-1 Inhibitors in Patients With Advanced Urothelial Carcinoma From a Real-World Experience
    Sun, Fengze
    Wang, Dawei
    Liu, Aina
    Wang, Tianqi
    Zhang, Dongxu
    Yao, Huibao
    Sun, Kai
    Zhou, Zhongbao
    Lu, Guoliang
    Wu, Jitao
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [50] Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective Study
    Lee, Junho
    Lim, Sung Hee
    Chung, Jae Hoon
    Song, Wan
    Sung, Hyun Hwan
    Jeong, Byong Chang
    Park, Se Hoon
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 871 - 876